RE:Thoughts on today's NRYou can reference my previous posts on this board with my DD, as to why I think Management doesnt have the best interest fro shareholders. When you dont own any shares, you will raise money at any cost to pay for salaries and business lunches.
Todays News is troubling to me for several reasons already mentioned:
IND application for the FDA? Why would the company do this when the FDA has COVID 19 acceleration programs. The "CTAP" or Coronavirus Treatment Accreleration Program was put in place becuase the IND application is so combersome and time consuming, the virus will have been through the world population by them time it got approved. Did NP-120 get denied CTAP?
I dont mean to upset feelings I am just wuoting fact here but NP-120 was made in the 1970s, its a repurposed drug with a history non of us know. Was it denied by the FDA in the 1970s? There has to be a reason the market repriced a PP from .58 to .35 with terrible structure and enough warrants to kill any forward price action.
The Company used to Halt for any news, to a point it was laughable but now when you want to gather attention, it releases US news on a US holiday. I dont want to beat up on the shareholders here but the Management has handled this poorly from day 1, besided the obvious PUMP.
If more news isnt around the corner and credible, i think this play will go back to before Covid prices now that Management has wages secured for a year or two IMHO. The company has Covid pictures on its website and then this in the NR,
The company is posting in the news release again:
"The company cautions that while it is preparing to begin phase 2 clinical trials shortly, it is not making any express or implied claims that ifenprodil is an effective treatment for acute lung injury (ALI), the COVID-19 virus, or any other medical condition at this time."
FDA is saying :
"FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program (CTAP). It uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful. We continue to support clinical trials that are testing new treatments for COVID so that we gain valuable knowledge about their safety and effectiveness."
I want you all to make money, Just understand that the Bio Sector is its own beast. Why did the FDA not accept NP-120 into CTAP?
GOOD LUCK TO ALL